Multiple Sclerosis - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 812 pages report, published by Global Markets Direct

Report ThumbnailJune-2017
Multiple Sclerosis - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis - Pipeline Review, H1 2017, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape.

Multiple sclerosis (MS) is a potentially debilitating disease in which body's immune system eats away at the protective sheath (myelin) that covers nerves. Damage to myelin causes interference in the communication betwee

Read More
  • List of Figures
  • Number of Products under Development for Multiple Sclerosis, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Top 10 Routes of Administration
Read More
  • List of Tables
  • Number of Products under Development for Multiple Sclerosis, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017
  • Number of Products under Development by C
Read More
  • Table of Contents
  • Table of Contents 2
  • Introduction 9
  • Multiple Sclerosis - Overview 10
  • Multiple Sclerosis - Therapeutics Development 11
  • Multiple Sclerosis - Therapeutics Assessment 48
  • Multiple Sclerosis - Companies Involved in Therapeutics Development 70
  • Multiple Sclerosis - Drug Profiles 160
  • Multiple Sclerosis - Dormant Projects 746
  • Multiple Sclerosis - Discontinued Products 763
  • Multiple Sclerosis - Product Development Milestones 766
  • Appendix 778
Read More

Please select a license type

Share

Related Products

Global Markets DirectMultiple Sclerosis - Pipeline Review, H1 2017Product ThumbnailMultiple Sclerosis - Pipeline Review, H1 2017, Industry ReportProduct #: 829008
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved